Patient’s characteristics | Total, N = 111 | 90-day survivors, N = 75 | 90-day non-survivors, N = 36 | p |
---|---|---|---|---|
Sex, male—n (%) | 71 (64) | 51 (68) | 20 (56) | 0.2858 |
Age—year | 48 [32.5–63] | 42 [29–58] | 56.5 [42–79] | 0.0013 |
BMI—kg/m2 | 25.2 [22.9–28.7] | 25.1 [23–28.3] | 25.7 [22.4–29.1] | 0.9673 |
Medical history | ||||
CIC—n (%) | 3 (2.7) | 2 (3) | 1 (3) | 1.0000 |
COPD—n (%) | 3 (2.7) | 2 (3) | 1 (3) | 1.0000 |
CKD—n (n) | 5 (4.5) | 1 (1) | 4 (11) | 0.0374 |
Chronic HBP—n (%) | 25 (22.5) | 12 (16) | 13 (36) | 0.0277 |
Psychiatric—n (%) | 34 (30.6) | 22 (29) | 12 (33) | 0.6668 |
Burn characteristics | ||||
TBSA—% | 35 [25–53.5] | 32 [22–45] | 57 [31–70] | < 0.0001 |
Deep burn BSA—% | 21 [10–40] | 17 [7–30] | 42 [15–61] | 0.0001 |
Inhalation injury—n (%) | 54 (48.6) | 28 (37) | 26 (72) | 0.0012 |
Characteristics during hospitalization | ||||
Mechanic ventilation—n (%) | 82 (73.9) | 52 (69) | 30 (83) | 0.1799 |
DPP3admin (ng/mL) | 30.6 [22.4–53.6] | 27.1 [19.4–40.2] | 53.3 [29.5–104] | < 0.0001 |
DPP3day3 (ng/mL) | 17.3 [11.8–25.2] | 14.1 [11.5–20.6] | 22.1 [16.6–30.8] | 0.0102 |
Screat—μmol/L | 72.5 [56.5–92] | 70 [54.8–81.3] | 90.5 [67.3–138.3] | 0.0003 |
Lactate—mmol/L | 3.5 [2.0–5.7] | 2.7 [1.7–4.6] | 5.2 [3.5–8] | < 0.0001 |
Bilirubin—mmol/L | 14.0 [9.3–21.3] | 12.9 [9–19.3] | 18 [10.9–25.9] | 0.0945 |
Platelet—G/L | 250 [185–304] | 236 [183–277] | 279 [180–372] | 0.3840 |
Length of hospitalization—days | 90 [35.5–90] | 41 [26–61] | 18 [2–32.5] | < 0.0001 |
RRT—n (%) | 24 (21.6) | 5 (7) | 28 (78) | < 0.0001 |
Severity scores | ||||
SOFA | 4 [1–7] | 2 [0–4] | 6.5 [3.3–9.8] | < 0.0001 |
ABSI | 8 [7–11] | 8 [6–9] | 11 [9–13] | < 0.0001 |
SAPS2 | 33 [23–47] | 28 [20–42] | 47 [33–62] | < 0.0001 |
UBS | 100 [52.5–166] | 84 [45–132] | 184 [86–249] | < 0.0001 |
Hemodynamic on admission | ||||
Echocardiography, n (%) | 59 (53) | 33 (44) | 26 (72) | 0.0078 |
Systolic cardiac dysfunction, n (%) | 10 (9) | 2 (3) | 8 (22) | 0.0163 |
Circulatory failure, n (%) | 53 (48) | 24 (32) | 29 (81) | < 0.0001 |
MAP in mmHg | 79 [70–95] | 84 [73–97] | 73 [64–85] | 0.0104 |
Volume of crystalloids at day 1 | 8250 [3700–15,000] | 6700 [3300–12,800] | 13,400 [6430–18,380] | 0.0018 |
Volume of crystalloids at day 2 | 3000 [1000–5650] | 2500 [1000–5150] | 4000 [2000–7500] | 0.1078 |